Ramsay Générale de Santé SA (GDS.PA)
EUR 11.5
(0.44%)
EUR 11.5
(0.44%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 125 Million EUR | 5.75% |
| 2022 | 118.2 Million EUR | 6.29% |
| 2021 | 111.2 Million EUR | -0.18% |
| 2020 | 111.4 Million EUR | 2.67% |
| 2019 | 108.5 Million EUR | 9.71% |
| 2018 | 98.9 Million EUR | 45.87% |
| 2017 | 67.8 Million EUR | 8.83% |
| 2016 | 62.3 Million EUR | 13.89% |
| 2015 | 54.7 Million EUR | 30.86% |
| 2014 | 41.8 Million EUR | 25.9% |
| 2013 | 33.2 Million EUR | 0.0% |
| 2012 | 33.2 Million EUR | -4.05% |
| 2011 | 34.6 Million EUR | -2.26% |
| 2010 | 35.4 Million EUR | 7.93% |
| 2009 | 32.8 Million EUR | -14.58% |
| 2008 | 38.4 Million EUR | 9.71% |
| 2007 | 35 Million EUR | 9.38% |
| 2006 | 32 Million EUR | 18.08% |
| 2005 | 27.1 Million EUR | 18.86% |
| 2004 | 22.8 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 125 Million EUR | 5.75% |
| 2023 Q2 | 121.7 Million EUR | 0.0% |
| 2023 Q3 | 121 Million EUR | -0.58% |
| 2023 Q4 | 125 Million EUR | 3.31% |
| 2023 Q1 | 121.7 Million EUR | 2.96% |
| 2022 Q2 | 115.3 Million EUR | 0.0% |
| 2022 Q3 | 118.2 Million EUR | 2.52% |
| 2022 Q4 | 118.2 Million EUR | 0.0% |
| 2022 FY | 118.2 Million EUR | 6.29% |
| 2022 Q1 | 115.3 Million EUR | 3.69% |
| 2021 FY | 111.2 Million EUR | -0.18% |
| 2021 Q1 | 116.4 Million EUR | 4.49% |
| 2021 Q4 | 111.2 Million EUR | 0.0% |
| 2021 Q2 | 116.4 Million EUR | 0.0% |
| 2021 Q3 | 111.2 Million EUR | -4.47% |
| 2020 Q3 | 111.4 Million EUR | -5.43% |
| 2020 Q1 | 117.8 Million EUR | 8.57% |
| 2020 Q2 | 117.8 Million EUR | 0.0% |
| 2020 Q4 | 111.4 Million EUR | 0.0% |
| 2020 FY | 111.4 Million EUR | 2.67% |
| 2019 Q2 | 99.2 Million EUR | 0.0% |
| 2019 FY | 108.5 Million EUR | 9.71% |
| 2019 Q1 | 99.2 Million EUR | 0.3% |
| 2019 Q3 | 108.5 Million EUR | 9.38% |
| 2019 Q4 | 108.5 Million EUR | 0.0% |
| 2018 FY | 98.9 Million EUR | 45.87% |
| 2018 Q4 | 98.9 Million EUR | 0.0% |
| 2018 Q3 | 98.9 Million EUR | -7.48% |
| 2018 Q2 | 106.9 Million EUR | 0.0% |
| 2018 Q1 | 106.9 Million EUR | 57.67% |
| 2017 Q1 | 67.09 Million EUR | 7.7% |
| 2017 Q4 | 67.8 Million EUR | 0.0% |
| 2017 Q3 | 67.8 Million EUR | 1.04% |
| 2017 Q2 | 67.1 Million EUR | 0.0% |
| 2017 FY | 67.8 Million EUR | 8.83% |
| 2016 FY | 62.3 Million EUR | 13.89% |
| 2016 Q4 | 62.3 Million EUR | 0.0% |
| 2016 Q3 | 62.3 Million EUR | 5.06% |
| 2016 Q2 | 59.3 Million EUR | 0.0% |
| 2016 Q1 | 59.3 Million EUR | 8.41% |
| 2015 FY | 54.7 Million EUR | 30.86% |
| 2015 Q2 | 54.1 Million EUR | 0.0% |
| 2015 Q3 | 54.7 Million EUR | 1.11% |
| 2015 Q4 | 54.7 Million EUR | 0.0% |
| 2015 Q1 | 54.1 Million EUR | 0.0% |
| 2014 Q2 | 40 Million EUR | 5.54% |
| 2014 Q1 | 37.9 Million EUR | 9.86% |
| 2014 FY | 41.8 Million EUR | 25.9% |
| 2013 Q2 | 33.2 Million EUR | 2.15% |
| 2013 Q1 | 32.5 Million EUR | -0.91% |
| 2013 FY | 33.2 Million EUR | 0.0% |
| 2013 Q4 | 34.5 Million EUR | 4.23% |
| 2013 Q3 | 33.1 Million EUR | -0.3% |
| 2012 FY | 33.2 Million EUR | -4.05% |
| 2012 Q2 | 33.2 Million EUR | 0.91% |
| 2012 Q1 | 32.9 Million EUR | -2.08% |
| 2012 Q4 | 32.8 Million EUR | -2.38% |
| 2012 Q3 | 33.6 Million EUR | 1.2% |
| 2011 Q1 | 35 Million EUR | 0.57% |
| 2011 Q4 | 33.6 Million EUR | -2.33% |
| 2011 Q3 | 34.4 Million EUR | -0.58% |
| 2011 FY | 34.6 Million EUR | -2.26% |
| 2011 Q2 | 34.6 Million EUR | -1.14% |
| 2010 FY | 35.4 Million EUR | 7.93% |
| 2010 Q4 | 34.8 Million EUR | -3.33% |
| 2010 Q3 | 36 Million EUR | 1.69% |
| 2010 Q2 | 35.4 Million EUR | 5.99% |
| 2010 Q1 | 33.4 Million EUR | 0.0% |
| 2009 Q2 | 32.8 Million EUR | 0.0% |
| 2009 FY | 32.8 Million EUR | -14.58% |
| 2008 FY | 38.4 Million EUR | 9.71% |
| 2007 FY | 35 Million EUR | 9.38% |
| 2006 FY | 32 Million EUR | 18.08% |
| 2005 FY | 27.1 Million EUR | 18.86% |
| 2004 FY | 22.8 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Clariane SE | 28.29 Million EUR | -341.743% |
| LNA Santé SA | 148.29 Million EUR | 15.71% |